Olinciguat, an Oral sGC Stimulator, Exhibits Diverse Pharmacology Across Preclinical Models of Cardiovascular, Metabolic, Renal, and Inflammatory Disease

Overview of attention for article published in Frontiers in Pharmacology, April 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

So far, Altmetric has seen 8 X posts from 4 X users, with an upper bound of 9,376 followers.

RT @Cyclerion: Cyclerion's most recent publication was accepted to @FrontPharmacol! Our article describes the pharmacokinetics, tissue dist…

One of my new favorite biotech companies. $CYCN https://t.co/6dWOykn7cN

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.